ESR1 and breast carcinoma: Results were similar when analyses were stratified according to estrogen receptor status: estrogen receptor–positive breast cancer (HR = 0.81, 95% CI = 0.65 to 1.02) and estrogen receptor–negative breast cancer (HR = 0.77, 95% CI = 0.60 to 0.98).